Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Journal of the American Association for Laboratory Animal Science : JAALAS|July 7, 2018
Effects of Nesting Material on the Toxicologic Assessment of Cyclophosphamide in Crl:CD1(ICR) MiceCatherine P Brochu, Christina L Winnicker, Anne L Provencher, et al.The Journal of Steroid Biochemistry and Molecular Biology|May 30, 1998
Binding characteristics of novel nonsteroidal antiestrogens to the rat uterine estrogen receptorsC Martel, L Provencher, X Li, et al.Endocrinology|May 16, 1998
Comparison of the effects of the new orally active antiestrogen EM-800 with ICI 182 780 and toremifene on estrogen-sensitive parameters in the ovariectomized mouseC Martel, C Labrie, A Bélanger, et al.Current Oncology (Toronto, Ont.)|August 19, 2016
Is clinical breast examination important for breast cancer detection?L Provencher, J C Hogue, C Desbiens, et al.Current Oncology (Toronto, Ont.)|March 5, 2008
Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working GroupJ R Mackey, M Clemons, M A Côté, et al.Current Oncology (Toronto, Ont.)|August 13, 2009
The role of HER2-targeted therapies in women with HER2-overexpressing metastatic breast cancerS Dent, Sh Verma, J Latreille, et al.Current Oncology (Toronto, Ont.)|October 29, 2009
The role of neoadjuvant (HER)2-targeted therapies in (HER)2-overexpressing breast cancersJ Lemieux, M Clemons, L Provencher, et al.Current Oncology (Toronto, Ont.)|August 11, 2010
Optimizing the management of HER2-positive early breast cancer: the clinical realitySu Verma, S Lavasani, J Mackey, et al.Genes & Development|August 21, 2007
A Rap GTPase interactor, RADIL, mediates migration of neural crest precursorsGromoslaw A Smolen, Benjamin J Schott, Rodney A Stewart, et al.British Journal of Cancer|February 21, 2013
Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancerD W Miles, S L de Haas, L Y Dirix, et al.Pageof 4